Patients with COVID-19 can develop pneumonia that leads to acute respiratory distress syndrome requiring invasive care such as extracorporeal membrane oxygenation (ECMO). Although reported mortality is high (39%) for patients with COVID-19 undergoing ECMO, it is not clear what other factors may be associated with this outcome.
Using a national database, Gallegos-Koyner and colleagues matched comorbidities and socioeconomic factors and compared outcomes between patients with COVID-related pneumonia and those with non–COVID-19 pneumonia who were treated with ECMO. They found the following:
Patients in both groups were similar in age (45–46 years) and mostly male.
Those with COVID-19 had higher mortality, longer stays, higher hospital costs, and less likelihood of being discharged home.
Findings show that patients with COVID-19 undergoing ECMO had poorer outcomes than patients with non–COVID-19 pneumonia undergoing ECMO.
See Article, pp 104–110
Nurse burnout remains a significant problem affecting nurses’ health and patients’ satisfaction and care. Although stand-alone...